key: cord-0139951-yqgpo7v9
authors: McKennan, Chris; Sang, Zhe; Shi, Yi
title: A novel framework to quantify uncertainty in peptide-tandem mass spectrum matches with application to nanobody peptide identification
date: 2021-10-15
journal: nan
DOI: nan
sha: a002569cd50df6a67da024eb86bf1ddca267d262
doc_id: 139951
cord_uid: yqgpo7v9

Nanobodies are small antibody fragments derived from camelids that selectively bind to antigens. These proteins have marked physicochemical properties that support advanced therapeutics, including treatments for SARS-CoV-2. To realize their potential, bottom-up proteomics via liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been proposed to identify antigen-specific nanobodies at the proteome scale, where a critical component of this pipeline is matching nanobody peptides to their begotten tandem mass spectra. While peptide-spectrum matching is a well-studied problem, we show the sequence similarity between nanobody peptides violates key assumptions necessary to infer nanobody peptide-spectrum matches (PSMs) with the standard target-decoy paradigm, and prove these violations beget inflated error rates. To address these issues, we then develop a novel framework and method that treats peptide-spectrum matching as a Bayesian model selection problem with an incomplete model space, which are, to our knowledge, the first to account for all sources of PSM error without relying on the aforementioned assumptions. In addition to illustrating our method's improved performance on simulated and real nanobody data, our work demonstrates how to leverage novel retention time and spectrum prediction tools to develop accurate and discriminating data-generating models, and, to our knowledge, provides the first rigorous description of MS/MS spectrum noise.

Nanobodies are minimal binding units derived from camelid heavy-chain antibodies [1] . Unlike conventional human IgG antibodies, these proteins are soluble, have remarkable tissue penetration, and can be bioengineered in large quantities [2] . These characteristics, along with their strong antigen-binding affinity and sequence similarities to IgG, make them promising, cost-effective candidates to study humoral immunity and for therapeutics to diagnose and combat an array of diseases, including cancer, inflammation, and infectious diseases [2] . Classes of nanobodies have even been shown to neutralize SARS-CoV-2 [3] .

To help effectuate their clinical potential, bottom-up proteomics has recently been proposed as a way to identify antigen-specific nanobodies at the proteome scale [4] . Briefly, a camelid is inoculated with an antigen to generate an immune response, its blood collected, and a custom database T containing the constituent peptide sequences of millions of nanobody proteins that may exist in the camelid is created. Antigen-specific nanobodies are then isolated, digested with an endoprotease to yield peptides, and subjected to liquid chromatography-tandem mass spectrometry (LC-MS/MS). LC-MS/MS separates, isolates, and fragments peptides to generate MS/MS spectra whose LC retention times (the times at which the spectra were generated) and peaks can be used to identify their parent peptides in T (Figure 1(a) ). Since nanobodies can then be reconstructed by their identified constituent peptides [4, 5] , correctly matching spectra to their generating peptides is an essential component of this pipeline.

The goal of peptide-spectrum matching is to assign to each spectrum its most likely generating peptide, and quantify the uncertainty in said assignments [6] . While methods of varying complexity have been developed [7] [8] [9] [10] [11] [12] , nearly all rely on a target-decoy paradigm to achieve these aims. In brief, each observed spectrum S is searched against a database T of candidate "target" peptides whose predicted spectra are used to define scores Score(P, S) reflecting the plausibility peptide P ∈ T generated S. The spectrum's inferred match isP = argmax P ∈T Score(P, S), whereP may be incorrect if (i) T contains S's true generator P * but Score(P , S) > Score(P * , S), or (ii) T does not contain the analyte that generated S [13] . We refer to these as score-ordering and database incompleteness errors, respectively. To quantify these uncertainties, the scoring procedure is repeated with T replaced with a database D of "decoy" peptides not present in T . As decoy peptides do not generate spectra, decoy scores should ideally mirror scores from database incompleteness errors. However, to also control score-ordering errors, it is necessary to assume the maximum decoy and non-generating target peptide scores, z (D) = max P ∈D Score(P, S) and z (T \{P * }) = max P ∈T \{P * } Score(P, S), are identically distributed [13] , where z (A) will typically be small if peptides in A are dissimilar to S's generator P * ∈ T (and vice-versa). As peptides in D are dissimilar to target peptides P ∈ T , z (D) and z (T \{P * }) will only have the same distribution if non-generating target peptides do not resemble generating peptides.

While this target-decoy paradigm performs well in relatively simple proteomes, the similarity between nanobody peptides in T implies non-generating peptides likely resemble generating peptides (Figure 1(b) ), which belies the above assumption necessary to control score-ordering errors. As a result, Figure 1 (c) suggests existing target-decoy-based methods return an abundance of score-ordering errors at nominally low false discovery rates in nanobody proteomes, which is congruent with recent experimental evidence indicating these methods significantly underestimate error rates in nanobody applications [4] . One solution might be to use the method proposed in Li et al. [14] , which is, to our knowledge, the only method to avoid the above assumption. However, this ignores database incompleteness errors, and is therefore not applicable to real proteomic data [13] . A second option might be to use the method proposed in Xiang et al. [4] , which requires users have access to a second custom nanobody peptide database generated from a second camelid inoculated with a completely different antigen to filter identifications made by an existing target-decoy method. While this method significantly outperformed the target-decoy method its authors compared it with [4] , its second database requirement is impractical in more modest experiments, it is only able to identify a small class of nanobody peptides, and, as we show in Section 6.3, it likely fails to suitably account for score-ordering errors.

In this work, we address these issues by casting peptide-spectrum matching as a model selection problem with an incomplete model space, where we use observed LC retention times and spectra to distinguish between different peptide "models". Our framework and method require only a single nanobody peptide database and are, to our knowledge, the first to account for both score-ordering and database incompleteness errors without assuming the former mirror decoy matches, which we prove helps avoid error rate inflation and, using real data, show facilitates uniquely accurate and powerful inference in nanobody proteomes. While our work is motivated by nanobody proteomes, it is also applicable to other proteomic data, including proteogenomic and metaproteomic data, in which peptide sequence similarity precludes the use of existing methods [15] . We make several other important contributions:

(a) We show how cutting edge, deep learning-based retention time and spectrum prediction tools can be used to develop discriminating scoring functions.

(b) We build a generative model to assess peptide model selection uncertainty that incorporates retention time, inter-spectra heterogeneity, the relationship between mass accuracy and intensity, and the dependence of observed on predicted peak intensities.

(c) We develop a novel and mathematically rigorous model for spectrum noise.

While others have attempted to use the tools in (a), they only use them for downstream error rate control, ignore retention time, or do not exploit the dependence between predicted and observed peak intensities [15] [16] [17] . Our models in (b) and (c) transcend those in Li et al. [14] , which, to our knowledge, is the only other work to consider peptide model selection uncertainty, and (c) eclipses the standard, but incorrect, assumption that noise peaks occur uniformly at random [14, 18] . The rest of the article is organized as follows. We describe the data in Section 2, outline our assumptions and framework in Section 3, and prove existing target-decoy-based methods tend to inflate error rates in nanobody proteomes in Section 3.2. We then derive our data generating model in Section 4, demonstrate the efficacy of our method, MSeQUiP (Quantifying Uncertainty in Peptide-spectrum matches), using simulated and real data in Sections 5 and 6, and end with a discussion in Section 7. The proofs of all theoretical statements are given in the Supplement.

Each datum consists of an observed MS/MS spectrum, retention time pair, where retention time is the time at which the generating analyte eluted off the LC column and reflects the analyte's hydrophobicity. We process MS/MS spectra by consolidating peaks with massto-charge (m/z) ratios ≤ 40 parts per million apart to reduce the dependencies between high-resolution peaks [19] , and deisotope and assign peak charge states by extending the method proposed in Goldfarb et al. [20] . We use Prosit [16] to generate a predicted spectrum and indexed retention time (iRT) for each peptide in a given target T and decoy D database, where iRT is a unitless quantity predictive of retention time. We apply the same processing procedures to predicted spectra as we do for observed spectra. For the purposes of Figure 3 and Section 5, our data example in Section 6 contains two groups, group 1 and group 2, of three LC-MS/MS datasets derived from two different classes of nanobodies. Sections S1 and S2.1 in the Supplement contain additional processing and data details.

We assume each spectrum's generating peptide has the same charge, and generalize to multiple charge states in Section S3.1 of the Supplement. We let T and D be disjoint target and decoy peptide databases, where D, which is created by reversing peptides in T and contains no generating peptides, will be used to help quantify uncertainty in Section 3.1. For [m] = {1, . . . , m}, we let S g and t g be the observed spectrum and retention time for spectrum g ∈ [q], and define the random indicator H g = I(spectrum g was generated by some P ∈ T ). Our goal is to use the observed data, S g and t g , to define spectrum g's most likely generator,P g , and estimate our uncertainty inP g while allowing for the possibility that spectrum g's generator is not in T .

Let P ∈ T and define G g (P ) to be the event {peptide P generated spectrum g} and N g to be the event {all peaks in spectrum g are noise peaks}, where we characterize noise peaks in Section 4.1. Then because G g (P ) ⊆ {H g = 1} and assuming {G g (P )} P ∈T a priori have equal measure, Pr{G g (P ) | S g , t g } = Pr{G g (P ) | H g = 1, S g , t g } Pr(H g = 1 | S g , t g ) = BF g (P )

P ∈T BF g (P ) Pr(H g = 1 | S g , t g ) (3.1a)

BF g (P ) = Pr{S g , t g | G g (P )}/ Pr(S g , t g | N g ).

(3.1b)

The Bayes factor BF g (P ) assesses the evidence in favor of G g (P ) as compared to the noise model N g . Since Pr{G g (P ) | S g , t g } and BF g (P ) have the same ordering as functions of P , BF g (P ) is the optimal scoring function in the sense that the inferred match argmax P ∈T BF g (P ) is the Bayes optimal classifier. We use this reasoning to definê P g = argmax P ∈T BF g (P ), PSM-fdr g = 1 − Pr{G g (P g ) | S g , t g }, DI-fdr g = Pr(H g = 0 | S g , t g ), (3.2) where the peptide-spectrum match (PSM) local false discovery rate, PSM-fdr g , is our inferential target, and quantifies our uncertainty in spectrum g's inferred matchP g . The decomposition of Pr{G g (P ) | S g , t g } in (3.1a) is a reflection of our treatment of peptide-spectrum matching as a model selection problem with an incomplete model space T , and implies PSM-fdr g is an increasing function of the two measures of uncertainty discussed in Section 1. The first is the score-ordering error rate 1−Pr{G g (P g ) | H g = 1, S g , t g } = 1−BF g (P g )/ P ∈T BF g (P ), which evaluates the data's capacity to differentiate between potential generators, i.e. models, in T , and helps control score-ordering errors. The second is the database incompleteness (DI) error rate DI-fdr g , which quantifies our uncertainty as to whether T contains spectrum g's generator, and helps control database incompleteness errors. The above observation that BF g (P ) is interpretable as a scoring function motivates using the decoy database D, whose elements do not overlap with T , to approximate the distribution of scores for spectra whose generators are not in T . The following proposition formalizes this and motivates an estimator for DI-fdr g .

BF g (P ) be spectrum g's target and decoy score.

q , H q ) are independent and identically distributed and (ii) z

If Assumptions (i) and (ii) hold, this suggests we can determine a p-value for the null hypothesis H g = 0 and use the method proposed in Storey [21] to estimate DI-fdr g . Assumption (i) is technical and (ii) requires decoy scores mirror target scores for spectra with generators not in T , which we show appears to hold in Section S3.3 of the Supplement. We derive an estimator for BF g (P ) in Section 4, which, in conjunction with our estimator for DI-fdr g , is sufficient to estimate PSM-fdr g .

Our framework in Section 3.1 explicitly accounts for score-ordering and database incompleteness errors, where we use peptide model uncertainty to determine the score-ordering error rate and, as illustrated in Proposition 3.1, only use the decoy database to control database incompleteness errors via DI-fdr g . By contrast, Lemma 3.1 below, which provides a compendious description of the theory presented in Section S3.2 of the Supplement, shows that existing target-decoy methods that use the decoy database to control both score-ordering and database incompleteness errors risk inflating PSM-fdr's.

Lemma 3.1. Suppose for some scoring function Score, Assumptions (i) and (ii) of Proposition 3.1 hold for z

Then if the densities for z (T ) g and z (D) g exist and are known, the estimators for PSM-fdr g implied under the target-decoy assumptions listed in Keich et al. [13] are O(DI-fdr g ).

This shows existing target-decoy-based estimates for PSM-fdr g are small if and only if DI-fdr g is small, and have virtually no dependence on the score-ordering error rate. As the scoreordering error rate will likely be large in nanobody proteomes even if DI-fdr g is small, Lemma 3.1 implies target-decoy methods likely return excess false discoveries. We assume the densities for z (T ) g and z (D) g are known because they are estimated in practice [22] , and use Keich et al. [13] to characterize the target-decoy paradigm because it and its companion Keich et al. [23] are the only to consider score-ordering and database incompleteness errors.

Here, we present the data generating models Pr{S g , t g | G g (P )} and Pr(S g , t g | N g ) for P ∈ T ∪ D, which are used to determine BF g (P ). We assume S g and t g are independent conditional on G g (P ) or N g and that Pr{t g | G g (P )}/ Pr(t g | N g ) ∝ Pr{t g | G g (P )}. The latter is for convenience, and plays no role in our estimators in (3.2) . Therefore, we need only define Pr{t g | G g (P )}, Pr{S g | G g (P )}, and Pr(S g | N g ). Compendious descriptions of the former two are given in the left and right connected components of Figure 2 , and should be referenced while reading (4.3) and Algorithm 4.1 below. We define Pr(S g | N g ) at the end of the section. First, Pr{t g | G g (P )}, g ∈ [q], is defined as

where M is the length of the LC gradient, iRT P is P 's indexed retention time, and f (t) sig is a quadratic function. The logit helps remove any mean-variance relationship (Figure 3(a) ), and the mixture normal provides a sufficiently flexible model for t,g (Figure 3 (b)).

Our model for Pr{S g | G g (P )} is more complex. Suppose P 's predicted spectrum and S g , depicted in the top and bottom of Figure 2 , have n (P ) and n (Sg) peaks. Let m (P ) j , y (P ) j be P 's jth predicted peak's m/z and log-relative intensity, and define m Predicted peaks j with δ (P) (j) ≠ 0

Observed signal m/z Observed signal intensity Observed noise m/z Observed noise intensity

Information that is conditioned on Random spectrum-specific parameters Fixed global hyperparameters Observed data Color legend Figure 1 : A probabilistic graphical model depicting Pr{S g | Gg(P)}, where P's predicted peaks' m/z's and log-relative intensities {m (P) j , y (P) j } j2[n (P) ] are given in the plot of P's predicted spectrum. The leftmost node in the top row is known conditional on Gg(P), and we implicitly condition on the two rightmost elements. Roman numerals below causal arrows reference the steps in the data generating model outlined in Section ... Predicted peaks j with δ (P) (j) ≠ 0

Observed signal m/z Observed signal intensity Predicted peaks j with δ (P) (j) ≠ 0

Information that is conditioned on Random spectrum-specific parameters Fixed global hyperparameters Observed data Color legend Figure 1 : A probabilistic graphical model depicting Pr{S g | G g (P)}, where P's predicted peaks' m/z's and log-relative intensities {m (P) j , y (P) j } j2[n (P) ] are given in the plot of P's predicted spectrum. The leftmost node in the top row is known conditional on G g (P), and we implicitly condition on the two rightmost elements. Roman numerals below causal arrows reference the steps in the data generating model outlined in Section ... Predicted peaks j with δ (P) (j) ≠ 0 Predicted peaks j with δ (P) (j) ≠ 0

Information that is conditioned on Random spectrum-specific parameters Fixed global hyperparameters Observed data Color legend Figure 1 : A probabilistic graphical model depicting Pr{S g | G g (P)}, where P's predicted peaks' m/z's and log-relative intensities {m (P) j , y (P) j } j2[n (P) ] are given in the plot of P's predicted spectrum. The leftmost node in the top row is known conditional on G g (P), and we implicitly condition on the two rightmost elements. Roman numerals below causal arrows reference the steps in the data generating model outlined in Section ... 1 Figure 2 : An illustration of how P 's indexed retention time and predicted spectrum, which are known conditional on G g (P ), generate an observed retention time t g and spectrum S g . We implicitly condition on the two top rightmost nodes, and roman numerals below arrows reference steps in Algorithm 4.1. The map δ is defined in step (i) of Algorithm 4.1, where δ(j) = 0 if predicted peak j does not generate a peak in S g . If δ(j) = 0, δ(j) ∈ I sig indexes the signal peak in S g generated by predicted peak j. Noise peaks in S g are unlabeled. ) is assumed to be either a noisy realization of (m (P ) j , y (P ) j ) for some j ∈ [n (P ) ] or generated from some noise process, and determines (i) Assume m (P ) 1 < · · · < m (P ) n (P ) . For E (P ) gj = {predicted peak j generates a peak in S g }, 

gj }. Then I sig = Im(δ) \ {0} and I noi = {|I sig | + 1, . . . , n (Sg) } contain observed "signal" and "noise" peak labels.

(ii) Independently of (i), let (µ g , γ g ) T ∼ N (µ int + (q (Sg) 0.9 , 0) T , Σ int ).

(iii) Let δ −1 be the pre-image of δ andȳ

, be signal peak δ(j)'s relative part per million deviation from m T N ±c (x; a, b) is the density at x of the truncated normal with mean a, variance b, and truncated at ±c.

)} i∈I noi are independent and identically distributed given (δ, µ g ) and

for D were not generated by the noise process, and is standard in modern high mass accuracy data (ω 10) [24] . The map δ also informs observed peak ordering, where m (P )

. . , |I sig |}. Since no ordering exists for noise peaks i ∈ I noi , we order them in step (v) so that noise m/z's are increasing, which is equivalent to observing order statistics. Step (i) captures the fact that peaks predicted to be intense are more likely to generate peaks in S g (Figure 3 (c)), and β g in (4.5) relates observed and predicted relative intensities, where β g ≈ 1 implies observed intensities are approximately proportional to predicted relative intensities (Figure 3 (d)). The term γ g in step (ii) and (4.5a) is the difference in mean signal and noise log-intensities, since forȳ

noi | µ g , γ g , β g , σ 2 y,g , δ}. While an ideal prior on γ g would place no mass on negative values, our estimates for µ int , Σ int suggest this is unnecessary (Figure 3 (e)). The density d (m) sig in (4.6) determines a signal peak's mass accuracy, where higher density around 0 implies observed m/z's tend to be closer to their predicted m/z's, and the increasing function f (m) sig reflects the fact that more intense peaks have greater mass accuracy (Figure 3 (f)) [25] . Our assumption that noise log-intensities are drawn from a location family of distributions defined by D While others have developed nominal data generating models, they typically behave as scoring functions that can only rank peptides, as opposed to likelihoods capable of uncertainty quantification [18, [26] [27] [28] . To our knowledge, Li et al. [14] is the only other work to consider building a likelihood. Besides incorporating retention time and having application to high mass accuracy data, our model for Pr{t g , S g | G g (P )} transcends that in Li et al. by considering the covariation between noise and signal intensities (step (ii)), the dependence of observed intensities on predicted intensities (step (iii)), the link between peak intensity and mass accuracy (step (iv)), and, as indicated by the violet parameters in Figure 2 , inter-spectra heterogeneity. The latter is critical, as Figure S4 and Remark S5.24 in the Supplement show parameters vary substantially between spectra.

Of the input hyperparameters in Algorithm 4.1, it remains only to define D (m) noi,g (m | y), which is the density at m/z m for a noise peak in spectrum g with log-intensity y. One possibility is to assume D (m) noi,g (m | y) is uniform on an interval containing {m

, which is standard in low mass accuracy data [14, 18] . However, we show in Section S6.1 of the Supplement that the probability a noise peak gets mapped to a predicted peak is O(10 −5 ) in our high mass accuracy data, which, as suggested in Sections 5 and 6, is an underestimate in many m/z regions and inflates Bayes factors. To design a more appropriate model, the definition of 

Ordinary least squares (OLS) estimates for β g in (4.5). Blue line is N (β g ;μ β ,σ 2 β +v β );v β is the average, over group 2 spectra g, OLS estimate for Var(β g | β g ). (e): Estimates for γ g . Violet line is Here, λ (m) noi,g {m (P ) j | y} is the probability a noise peak in the gth observed spectrum gets mapped to the jth peak in P 's predicted spectrum, and the density d noi,g into interpretable pieces, we must account for the fact that noise peaks may be either manifestations of background noise, or genuine peptide fragments not contained in the generating peptide's predicted spectrum [14] , where d sig for peptide fragments, but, due to the homogeneity in background noise [29] , is likely uniform for background noise peaks. We address this by developing, to the best of our knowledge, the first mathematical description of MS/MS spectral noise in Section S4 of the Supplementary Material. Theorem 4.1 below outlines the key assumptions and results, which helps posit models and estimators for d has density B g (m) whose logarithm is continuous on a closed interval.

(b) Let X be an inhomogeneous Poisson point process with intensity Λ so that X = {peptide fragment m/z's that may produce noise peaks}. Then M j ; y} can be approximated as π noi,g {m , noise m/z. Assumption (a) is more general than the usual assumption that background noise is uniform on a closed interval [18] , and Assumption (b) describes the generative model for peptide fragment noise peaks. First, a fragment m/z X g is chosen from X , and then, like peptide fragment signal m/z's in step (iv) of Algorithm 4.1, its relative ppm mass error R g is drawn according to d (m) sig (r | y). Remark 4.5. We let X be random to account for our uncertainty in the exact position of all potential peptide fragment noise m/z's. The continuity of log{Λ(m)} assumes the density of potential fragment noise m/z's does not change too abruptly, and the continuity of log{p g (m)} implies the probability a fragment noise peak is generated from two neighboring regions is approximately proportional to the number of points in each region. We further justify these assumptions, as well as X 's Poisson assumption, in Section S4.1 using observed data and implicit assumptions from current best practices in the literature. In practice, and consistent with previous work [30] , we assume X is equivalent to {x > 0 : x is the m/z of a peptide fragment from a permuted peptide in the target database T }.

In addition to Remark S4.20 arguing that π noi,g {m (P ) j } has little dependence on g, (i) and (ii) in Theorem 4.1 imply d (m) noi,g and λ (m) noi,g can be modeled as

for continuous functions f j } is the probability background noise or a different peptide fragment begat the noise peak. Informally, the latter set of noise peaks are uniformly distributed around m (P ) j because the combinatorial explosion of, and therefore our uncertainty in, possible noise peptide fragment m/z's suggests they, and therefore their begotten noise peaks, are equally likely to appear at any point in a small interval surrounding m 

Having defined all generating models, we can now compute BF g (P ). For δ and r δ(j) defined in steps (i) and (iv) of Algorithm 4.1, BF g (P ) is the product of the below four terms:

The sets of hyperparameters Θ (rt) , Θ (gen) , Θ (int) , and Θ (ma) are defined in (4.3), (4.4), (4.5b) and steps (ii) and (v) of Algorithm 4.1, and (4.6) and (4.8), respectively. Larger values of any of the above likelihood ratios provide evidence supporting G g (P ), the hypothesis that spectrum g was generated by P , and are therefore interpretable as "scores" for retention time (rt), peak generation (gen), peak intensity (int), and mass-accuracy (ma). The second follows because BF (gen) g (P ) is interpretable as the ratio of the probabilities that we observe |I sig | peaks within ωppm of {m (P ) j } j:δ(j)>0 under G g (P ) and the noise model N g . We show how we calculate the above four terms in Section S5.1 of the Supplement.

Similar to previous work [10, 14, 16] , we use training data to estimate the hyperparameters, and derive three sets of estimators for spectra with precursor charges +2, +3 and ≥ +4. Briefly, we use an existing search engine to curate a set of high confidence peptide-spectrum matches, use the procedure outlined in Remark 4.2 to map predicted to observed peaks, and use standard methods to estimate all parameters except f noi ⊂ Θ (ma) and λ j . To avoid confusing notation, we outline their estimators below, and provide exact algorithms in Section S5.3 of the Supplement. In brief, we use high quality training spectra with their mapped signal peaks removed to estimate these functions. For each training spectrum g, we randomly draw a permuted peptide from the target database T with similar mass to spectrum g's precursor mass, fragment it in silico, and use the mapping procedure outlined in Remark 4.2 to map fragment to noise m/z's. These randomly generated fragments are samples from X defined in Remark 4.5, and represent fragments that could generate noise peaks. Having already estimated {f j }, we find it depends most on spectrum g's precursor mass ( Figure S3 ), and therefore partition spectra into precursor mass bins and assume λ noi,g = λ noi,h if g and h are in the same bin. Using Theorem 4.1, which shows λ noi,g can be approximated with a continuous function, we estimate λ noi,g nonparametrically as a piecewise-constant function using the above randomly sampled peptide fragment m/z's, and smooth the estimator with B-splines. Our estimator for +2 charged spectra is given in Figure 3 (i), where we only need one precursor mass bin for these spectra. j , and imply small peptide fragments tend to beget noise peaks. This has the effect of reducing the influence of low mass, non-specific fragment ions on Bayes factors. We illustrate the importance of this phenomenon is Section 6.

To assess the fidelity of our method, we developed a novel simulation technique that uses real nanobody data to generate simulated data, and contains three important features. First, these simulated data consisted of two sets of spectra to mirror real data prone to both database incompleteness and score-ordering errors. Second, all simulated spectra contained real noise peaks, which allowed us to assess the veracity of our new model for spectral noise outlined in Section 4.2. Lastly, we used hyperparameters derived from real group 1 and group 2 spectra, defined in Section 2, to simulate and analyze the data, respectively. As these groups of spectra were generated by different classes of nanobodies, this enabled evaluation of the inter-dataset generalizability of model hyperparameters defined in Section 4.3.

The first set of spectra were subject to database incompleteness errors. To simulate them, we note that in practice we apply a common peptide screening procedure for each spectrum S that discards a peptide if its predicted m/z lies outside a window of length L S surrounding S's generator's observed m/z, as peptides outside this window could not have generated S. We therefore followed previous work [31] and simulated these spectra by shifting generator m/z's of randomly chosen real group 1 spectra by 10m/z, which is substantially larger than L S for all spectra S. As such, these spectra were not generated by any screened peptides in the target database T , and were therefore prone to database incompleteness errors.

Spectra in the second set, which were prone to score-ordering errors, were generated by peptides in T and consisted of real noise and simulated signal peaks. Briefly, we used existing software [32] to identify group 1 spectra S (1) g , g = 1, . . . , q (1) =#group 1 spectra, whose generating peptides were likely in T , but whose inferred matches may have been ambiguous. We removed matching signal peaks from each spectrum so the resulting spectra S (1) noi,g , g = 1, . . . , q (1) , contained only noise peaks. We then added simulated signal peaks to S 

sig , σ 2 m,1 , σ 2 m,2 }} were estimated using group 1 data. To evaluate our method's sensitivity to distribution assumptions, we substituted the normal distribution in the expression for gj in (4.5a) with a t-distribution with four degrees of freedom. Each dataset contained 7382 such spectra.

We analyzed each simulated spectrum using hyperparameter estimates for Θ sig , D noi in Section 4.2, we repeated this procedure by estimating Bayes factors using the standard assumption that noise m/z's are uniform on the smallest interval containing the spectrum's observed m/z's [14, 18] . The results for 3 × 30 simulated datasets are given in Figure 4 , and shows that our method, MSeQUiP, is well-calibrated despite the data being simulated and analyzed using data derived from orthogonal nanobody classes. The inflation exhibited by the uniform noise model suggests noise m/z's are nonuniform, where, unlike our model, the uniform model underestimates the probability noise peaks match signal peaks, which inflates Bayes factors and overstates the confidence in inferred generators. Section S6 contains additional results evaluating our estimates for π 0 (see Figure 4 ) and comparing our Bayes factor score to other scoring functions. Since existing methods use different spectral features not considered by our data generating model to perform inference, it is unfair to use these simulations to compare MSeQUiP with existing methods. Instead, we postpone comparisons to our real data analysis below.

6 Real data application

We demonstrate the efficacy of our novel framework and method by analyzing real mass spectrometry data from Xiang et al. [4] , whose goal was to identify nanobodies with antigenspecific binding affinities. The authors inoculated a single llama (Lama glama) with a spe-

Nominal PSM-fdr Nominal PSM-fdr Nominal PSM-fdr Figure 4 : Simulation results for different π 0 's, defined as the fraction of simulated spectra generated by an analyte outside of T . The y-axis is the fraction of all simulated spectra in that PSM-fdr bin whose inferred generator did not match its true generator. The dashed red line is y = x.

cific antigen (denoted Antigen a ), and created a custom target nanobody and decoy peptide databases T a and D a . The entries of T a contain peptides derived from nanobody proteins that could exist in the llama, which include both non-specific and Antigen a -specific nanobodies. The authors then used two different experimental protocols to isolate Antigen a -specific nanobodies from the llama's blood plasma, and digested nanobodies to create two protocoldetermined groups of nanobody peptides. For purposes of calibration in Section 6.4, we also had access to a second database, T b , generated from a second llama inoculated with a different antigen (denoted Antigen b ), and defined its decoy database D b accordingly. Xiang et al. found the second protocol was more capable of isolating drug-quality nanobodies. We therefore focus our analysis on the resulting second group of three LC-MS/MS datasets, denoted D1, D2, and D3, and use the first group of datasets to estimate hyperparameters. We used the pipeline outlined in Section 2 to process all LC-MS/MS data and generate a library of predicted spectra and indexed retention times for peptides in T a ∪ D a and, for the purposes of Section 6.4, T b ∪ D b . Sections S2 and S7 in the Supplement contain additional data details and results for the first group of datasets.

Here, we demonstrate the importance of our statistical framework outlined in Section 3.1, whereby we cast peptide-spectrum matching as a model selection problem with an incomplete candidate model space. We define a peptide-spectrum match (PSM) to be an inferred peptide-spectrum pair, where PSM-fdr g indicates our uncertainty in the gth PSM. Recall from Section 3.1 that PSM-fdr g is an increasing function of the database incompleteness error rate, DI-fdr g , and the score-ordering error rate, where a large value of the latter implies a peptide in T a other than the inferred match could have generated the spectrum and, due to the similarity in their peptide sequences, is likely in nanobody proteomes. As small changes in a nanobody's sequence can have drastic effects on its binding properties [33] , controlling the score-ordering error rate is essential for identifying antigen-specific nanobodies. We were therefore interested in validating the conclusions of Lemma 3.1 that existing methods underestimate score-ordering error rates, and consequently, PSM-fdr's, and whether our framework can circumvent this.

To do so, we compared our proposed method MSeQUiP to three popular analysis pipelines, Relative intensity (%) which first score PSMs with one of Crux [11] , MS-GFplus [10] , or X!Tandem [8] , and subsequently use the post-processing software Percolator [12] to compute PSM-fdr's. To assess MSeQUiP's capacity to prune PSMs prone to score-ordering error, we compared its reported DI-fdr's and PSM-fdr's, where a small DI-fdr g but large PSM-fdr g implies that while the spectrum was likely generated by a peptide in T a , there is ambiguity in the inferred match due to its high score-ordering error rate. Since existing methods only report PSM-fdr's, we assessed whether they understate score-ordering errors by considering each significant PSM's delta score, defined as the difference in scores between the spectrum's highest and second highest scoring peptide. A small delta score is suggestive of a score-ordering error, since it indicates another peptide in T a besides the highest scoring inferred match could have generated the spectrum. To gauge if there is an excess of such ambiguous PSMs, and because existing pipelines are validated using simpler yeast proteomes [10] [11] [12] , we used delta scores derived from a yeast digest to determine each method's expected ambiguity. Figure 5 (a) contains the results at a 1% global false discovery rate. As suspected, existing methods return PSMs prone to score-ordering error, where Crux, MS-GFplus, and X!Tandem return over 2.5, four, and six times as many ambiguous nanobody PSMs compared to yeast. On the other hand, the grey bar, whose height gives the difference between the number of MSeQUiP-derived PSMs identified using DI-fdr g and PSM-fdr g , reflects MSeQUiP's capacity to prune PSMs prone to score-ordering error. The fact that some methods ostensibly identify more PSMs than MSeQUiP is inconsequential, since, as suggested by their ambiguous identifications and shown in Section 6.4, these methods inflate error rates.

We postulated that because Crux, MS-GFplus, and X!Tandem do not model predicted ion fragments' relative intensities, many of their ambiguities could be due to degeneracies in their predicted spectra, which could be resolved using MSeQUiP's relative intensity model. For example, predicted spectra, and therefore scores, for peptides that differ by amino acid isomers will be identical in existing methods, but will vary in MSeQUiP. This is tested in Figure 5 (b), which suggests MSeQUiP can resolve several ambiguous, but nominally significant, Crux-, MS-GFplus-, or X!Tandem-derived PSMs, where Figure 5 (c) gives an example. As expected, Figure 5 (b) also indicates that MSeQUiP's PSM-fdr's are large, i.e. 0.5, for many of these PSMs, implying MSeQUiP, unlike existing methods, is able to prune these ambiguous PSMs.

We next compare MSeQUiP to the method proposed in Xiang et al. [4] , which uses ad hoc criteria and the auxiliary database T b derived from the second llama inoculated with Antigen b , and defined in Section 6.1, to filter PSMs identified by existing software by treating T b as an additional decoy database. As this method can only identify nanobody peptides in T a that are specific to Antigen a , they restrict their attention to peptides overlapping the complementarity determining region 3 (CDR3) sequence, where the CDR3 region is a contiguous, nanobody-specific subsequence of amino acids that nearly completely determines a nanobody's binding properties [34] . Figure 6 (a) shows that this method is underpowered in comparison to MSeQUiP, where we consider a 5% global false discovery rate to be consistent with Xiang et al. [4] . Interestingly, 18% of the CDR3 PSMs identified by Xiang et al. were not identified by MSeQUiP, which could be because Xiang et al. estimated 14% of their identified nanobodies were false discoveries. Although the aforementioned filtering criteria likely alleviates some of the PSM ambiguity issues discussed in Section 6.2, their relatively large estimated false discovery proportion and failure to account for score-ordering error suggest they still return an excess of uncertain CDR3 PSMs, as CDR3 sequences typically only differ by a few amino acids [4] . We give one such PSM in Figure 6 (b), which was significant in Xiang et al. but, due to the similarity in fragment ion matches and predicted intensities, identified as ambiguous using MSeQUiP. This example also demonstrates the importance of our non-uniform noise m/z model described in Section 4.2. Unlike MSeQUiP, the probability of observing a noise m/z adjacent to the b1 ion's low predicted m/z is small under the uniform model, and nominally differentiates the top peptide from the bottom by increasing its Bayes Factor and decreasing its PSM-fdr by a factor of 500 (Figure 6(c) ).

We lastly assessed the fidelity of MSeQUiP's PSM-fdr to ensure it accurately reflects our uncertainty in PSMs. For example, if a set of PSMs have PSM-fdr equal to 0.1, then about 10% of them should be incorrect. Typical approaches to do so involve appending to T a a set of randomly generated "entrapment" peptides known to be absent from the biological sample, where a PSM whose peptide belongs to the entrapment set is incorrect [35] . However, this entrapment set is inappropriate, as differences between entrapment and nanobody peptides are much larger than those between incorrect inferred and true nanobody peptide generators. Instead, we took inspiration from Xiang et al. [4] and designed an entrapment procedure using the nanobody peptides in T b defined in Section 6.1. In brief, we re-analyzed spectra using the concatenated target and decoy databases T a ∪ T b and D a ∪ D b . Since spectra were generated by peptides whose parent nanobodies are Antigen a -specific, any inferred match from T b , which contains Antigen b -related nanobody peptides, would ideally be incorrect. However, due to the incompleteness of T a and cross-antigen degeneracies in non-CDR3 regions [34] , T b may contain legitimate generators absent from T a . To avoid overstating the number of false PSMs, we focused on CDR3 peptides, where, as discussed above, the antigen specificity of and variation in CDR3 sequences imply matches to CDR3 peptides in T b are incorrect [4] . We estimated the true false discovery rate in a nominal PSM-fdr window to be the fraction of CDR3 PSMs whose peptides lie in T b , and include results for all PSMs in Section S7.1 of the Supplement. While some PSMs with peptides in T a may also be incorrect, we argue in Section S7.2 of the Supplement that their contribution is likely minor. In addition to assessing PSM-fdr's, this procedure also helps judge the veracity of MSeQUiP's CDR3 PSMs from Section 6.3, which currently form the basis for antigen-specific nanobody inference [4] .

In addition to MSeQUiP and the three methods considered in Section 6.2, we used this entrapment procedure to assess the fidelity of PSM-fdr's reported by Prosit, the method proposed in Gessulat et al. [16] to re-score MaxQuant [24] PSMs. Notably, Prosit and MSeQUiP use the same predicted spectra to score PSMs. However, Prosit uses a black box algorithm that ignores score-ordering error to compute PSM-fdr's. We could not use this entrapment procedure to evaluate the method proposed in Xiang et al. [4] , as their reported error rates are defined by it. Figures 7(a) and 7(b) show that MSeQUiP is the only method to accurately estimate local and global PSM false discovery rates, where MSeQUiP's superb calibration is further verified in Figure S7 in the Supplement, which gives results for the first group of datasets discussed in Section 6.1. Since the primary difference between MSeQUiP and existing methods is the latter's failure to model score-ordering error, we sought to determine if an abundance of score-ordering errors could account for their inflated error rates. To do so, we compared delta scores between PSMs whose peptide belonged to one of T a or T b , where the latter set of delta scores typify those of false PSMs. Since, as discussed in Section 6.2, small delta scores are indicative of potential score-ordering errors, Figure 7 (c) suggests errant score-ordering is responsible for many of the existing methods' incorrect PSMs.

We have developed a novel framework and method to infer peptide-spectrum matches (PSMs) in tandem mass spectrometry data that casts peptide-spectrum matching as a model selection problem with an incomplete model space. To our knowledge, our work is the first to account for both score-ordering and database incompleteness errors without relying on the assumption that the former mirror decoy peptide matches. We demonstrated the improved performance of our method using simulated and real nanobody data.

Our Bayes factors BF g (P ) utilize recently developed deep learning-based spectrum and indexed retention time prediction tools. While we are not the first to leverage these tools, available software merely uses them to estimate error rates for previously identified PSMs [16] . Instead, our data generating model in Algorithm 4.1, which we use to define BF g (P ), illustrates how these tools can better identify PSMs by discriminating between a spectrum's potential peptide generators with similar amino acid sequences. It also implies spectrum prediction can be improved. For example, rather than predicting all peaks' relative intensities by optimizing their Euclidean distance from observed relative intensities [16] , steps (i) and (iii) in Algorithm 4.1 suggest separately predicting whether peaks are observed and their log-intensities could improve discriminatory power.

In addition to spectrum prediction, there are several important areas of future research. These include experimentally validating our results from Section 6, using CDR3 and other PSMs to quantify uncertainty in inferred nanobody proteins, using our framework to analyze proteogenomic, metaproteomic, and other notoriously challenging proteomic data, as well as designing integrated software to predict spectra, estimate hyperparameters from Algorithm 4.1, and infer PSMs.

Supplementary material for "A novel framework to quantify uncertainty in peptide-tandem mass spectrum matches with application to nanobody peptide identification" S1 LC-MS/MS data processing S1.1 Fragment de-isotoping and charge assignment

We converted Thermo RAW files to mzML format and de-isotoped MS/MS fragments and inferred their charge using an in-house method that extends Goldfarb et al. [20] . Our method scores observed and expected isotopic profile pairs, and, provided the score is large enough, replaces the observed profile's peak insensities and m/z's with its summed intensities and putative monoisotopic m/z. To describe the method, consider an MS/MS spectrum with precursor monoisotopic mass M p , charge z p ≥ 2, and precursor isolation window We assume that (i) isotopic peaks outside the precursor's isolation window could not have generated peaks in its corresponding MS/MS spectrum, and (ii) that the number of neutrons in each of the precursor's atoms is independent across atoms. Let where the estimatesβ j,k were obtained by first calculating Pr{F j (M )} for a randomly chosen subset of nanobody peptide b and y ion fragments, and subsequently regressing them onto M, . . . , M r j . Then assuming for simplicity that the precursor isolation window is centered at M p /z p ,

which suggests the following estimator for R j (G):

For observed fragment m/z's m f 0 , m f 1 , . . . , m f jmax and intensities O f 0 , O f 1 , . . . , O f jmax , isotopic profiles were scored using a standardized chi-squared statistic

. . , j max and t ≤ t max , where ω I = 15, η = 1.00284 is the average mass of a neutron, and t max is a user-defined quantity. We set t max in our application so that when we randomly chose j max + 1 peak intensities from a training MS/MS spectrum, t ≥ t max no more than 10% of the time. This threshold was large enough to recover nearly 95% of the matched b and y ion isotopic profiles from our training data. While most methods use a dot product to score potential isotopic profiles, our modified chi-squared statistic provided the greatest discriminating power. This method, which is computationally efficient due tô g j being a simple polynomial function, is available as a stand-alone R function.

Suppose peptide P is spectrum S's generating peptide, and let y (P ) j ∈ (0, 1] and y (S) δ(j) ∈ (0, 1], j = 1, . . . , n, be predicted fragment j's predicted and observed relative intensity, where δ(j) indexes the matched fragment in spectrum S. We used the Box Cox family of transformations to transform y (P ) j and y (S) δ(j) to ensure their joint distribution was approximately normal. That is, for λ ∈ R, we considered transformations of the form

and for a given pair (P ,S), maximized the profile likelihood

where J λ is the Jacobian of the transformation in (S1.1) and N 2 (x; µ, Σ) is the density at x of a bivariate normal with mean µ and variance Σ. We found that 70% of all 95% confidence intervals for λ computed using the (P ,S) pairs in our training data contained 0, suggesting that log(·) is an appropriate transformation for predicted and observed relative intensities.

The below method for extracting antigen-specific nanobodies was adapted from Xiang et al. [4] .

(a) Llama inoculation: A male llama was immunized with the antigen glutathione Stransferase (GST; Antigen a ) at a primary dose of 1mg, followed by three consecutive boosts of 0.5mg every 3 weeks.

(b) Constructing the target database: The blood from the animal was collected 10 days after the final boost. The mRNA from peripheral blood mononuclear cells was isolated and reverse-transcribed into cDNA, and VHH genes were PCR amplified. Next-generation sequencing (NGS) of the VHH repertoire was then performed, and sequences were translated into proteins and subsequently digested with chymotrypsin in silico to create the target database T a .

(c) Isolating antigen-specific nanobodies: VHH antibodies from the plasma of the llama were isolated using by a two-step purification protocol using protein G and protein A sepharose beads. Antigen-specific VHH antibodies were isolated by incubating the VHH antibodies with antigen-conjugated CNBr resin, and were subsequently washed. VHH antibodies were then released from the resin by using one of the following elution conditions: low pH (group 1; 0.1M glycine, pH 1, 2, and 3) or high pH (group 2; 1-100mM NaOH, pH 11, 12, and 13). The nanobodies released from the resin under low and high pH conditions contained nanobodies with predominantly low and high affinities for the antigen, respectively.

(d) Mass spectrometry analysis: Released VHH antibodies were reduced, alkylated, and in-solution digested using chymotrypsin. The resulting nanobody peptides were analyzed with a nano-LC 1200 that was coupled online with a Q Exactive TM HF-X Hybrid Quadrupole Orbitrap TM mass spectrometer (Thermo Fisher).

(e) Antigen b and T b : The target database T b was created by first inoculating a second llama with human serum albumin (Antigen b ). The remaining steps were analogous to those given in (a) and (b) above.

All searches were performed using chymotrypsin (cleavage C-terminal to F, W, Y, or L, but not N-terminal to P) to digest nanobody databases in silico, as well as a fixed carbamidomethylation modification on C and at most two variable oxidized M's. Other search engine-specific parameters are given below.

• MSeQUiP: We processed MS/MS spectra using the pipeline described in Section S1, and searched each spectrum using a 10ppm precursor and ω = 20ppm MS/MS mass tolerance. Spectra with fewer than 20 peaks were assumed to be uninformative and were not searched. After computing Bayes factors, we used Proposition 3.1 to define spectrum-specific p-values and the R package qvalue [36] to compute DI-fdr's.

• Crux, MS-GFplus, or X!Tandem + Percolator: We used Crux v3.2 [37] , MS-GFplus v20200805 [10] , or X!Tandem v20170201 [8] to score peptide-spectrum matches (PSMs), and Percolator v3.05.0 to compute PSM-fdr's. All searches were performed with a 10ppm precursor mass tolerance. With the exception of Crux, which discretizes MS/MS m/z space into bins of length 0.02m/z, MS/MS mass tolerance was set to 20ppm. Besides the enzyme and modification parameters given above, all other parameters were set to their software defaults. We note that by default, X!Tandem includes a number of additional post-translational modifications not considered by other search engines, including N-terminal acetylation, N-terminal deamination of Q to pyroglutamic acid, and a water loss for N-terminal E's.

• Prosit: We used MaxQuant v1.6.7.0 with a 10ppm precursor and 20ppm MS/MS mass tolerance to score PSMs, where besides the modifications listed above, all other parameters were set to their recommended defaults. We then used Prosit [16] to compute PSM-fdr's via their web server https://www.proteomicsdb.org/prosit/.

We partition spectra by their precursor charge into three groups: +2, +3, and ≥ +4, where the dependence of error-rate control on charge state has two sources. The first comes from estimates for DI-fdr g , which is defined in (3.2) . In practice, we estimate DI-fdr g by applying the method outlined in Storey [21] to each of the three charge-dependent sets of p-values p g defined in Proposition 3.1. The second source arises from the hyperparameters used to define BF g (P ), where some hyperparameters are assumed to depend on precursor charge. We detail this dependence in Section S5.

Here we study how estimates for the PSM-fdr behave in existing methods. To do so, we use the framework presented in Section 2 of Keich et al. [13] , whose theoretical set up applies to all existing methods that assume decoy peptide-spectrum matches (PSMs) are representative of incorrect matches [13] . Let Score(P, S) ∈ R be a scoring function that represents the plausability that peptide P ∈ T generated spectrum S, and let H g be as defined in Section 3. If H g = 1, let P g ∈ T be spectrum g's generating peptide, and define the following random variables:

Under this set-up, W g = max(X g , Y g ) is observable, but X g and Y g are not because H g and P g are unknown. Lemma S3.1 and Remarks S3.4 and S3.5 below shows that under the assumptions of Keich et al. [13] , estimates for PSM-fdr g that do not employ target-decoy competition are O(DI-fdr g ).

Lemma S3.1. Let W g , X g , Y g , H g be as defined and above, J g = I(the gth PSM is correct), and let (i), (ii), and (iii) below be the set of assumptions outlined in Section 2 of Keich et al. [13] , which may not necessarily hold in our data:

(i) X g and Y g are independent conditional on H g = 1.

(ii) The observable random variable Z g = max P ∈D Score(P, S g ) satisfies

are independent and identically distributed.

Assume the following hold:

are independent and identically distributed and Z g and W g have known densities with respect to Lebesgue measure.

Define PSM-fdr g = Pr(J g = 0 | W g = w) and PSM-fdr g to be the estimate for PSM-fdr g implied by conditions (i), (ii), and (iii) above that depends only on the known distributions of the observable random variables Z g and W g . Then PSM-fdr g = O{Pr(H g = 0 | W g )} = O(DI-fdr g ).

Proof. Under conditions (i), (ii), and (iii), PSM-fdr g can be expressed as

where Pr(Z g = w) and Pr(W g = w) are the densities of Z g and W g evaluated at w. Next, under (i) and (ii),

Pr(X g < w | H g = 1) Pr(Z g < w).

Therefore, since Pr(Z g = w) and Pr(W g = w) are known, Pr(X g < w | H g = 1) is also known under (i) and (ii), and can be expressed as

Then since the implied value of Pr(X g < w | H g = 1) is trivially bounded above by 1, we see that

which completes the proof.

Remark S3.1. It is assumed that D is a randomly drawn decoy database in Keich et al. [13] . In existing works that treat D as random, peptide sequences in D are typically generated by independently drawing each amino acid, with amino acid frequencies proportional to the number of times they appear in T [10, 11] .

Remark S3.2. Assumption (a) requiring Z g and W g have densities with respect to Lebesgue measure is a trivial assumption, and is satisfied by nearly all scoring functions. Assumption (b) is equivalent to Assumption (ii) in Proposition 3.1 in the main text.

Remark S3.3. The expression for PSM-fdr g in the proof of Lemma S3.1 is exactly what one would derive using the mixture-maximum procedure outlined in Section 3.3.2 of Keich et al. [13] .

Remark S3.4. It is easy to see that the Benjamini-Hochberg-like estimator Pr(Z g = w)/ Pr(W g = w) outlined in Section 3.2.1 of Keich et al. [13] and the estimator π 0 Pr(Z g = w)/ Pr(W g = w) proposed in Käll et al. [22] (which is exactly the Adaptive Benjamini-Hochberg estimator outlined in Section 3.2.2 of Keich et al. [13] ) are both bounded above by DI-fdr g /π 0 .

Remark S3.5. Lemma S3.1 and Remark S3.4 prove results for local false discovery rates. It is easy to extend these to global false discovery rates (FDRs) by noting that the global PSM and database incompleteness FDRs PSM-FDR g (w) = Pr(J g = 0 | W g ≥ w), DI-FDR g (w) = Pr(H g = 0 | W g ≥ w), satisfy PSM-FDR g (w) = E{PSM-fdr g (W g ) | W g ≥ w} and DI-FDR g (w) = E{DI-fdr g (W g ) | W g ≥ w} for PSM-fdr g (x) = Pr(J g = 0 | W g = x) and DI-fdr g (x) = Pr(H g = 0 | W g = x).

Lemma S3.1 and Remark S3.4 show that if conditions (i), (ii), and (iii) are assumed, as they are in existing target-decoy methods [13] , existing estimators for PSM-fdr g that do not employ target-decoy competition are O(DI-fdr g ). Lemma S3.2 below shows a similar result holds for those that do employ target-decoy competition.

Lemma S3.2. In addition to Assumptions (a), (b), and (c) from Lemma S3.1, assume the following holds:

Then the target-decoy competition-like estimator for the global false discovery rate, Pr(Wg<Zg∩Zg≥w)

where DI-fdr g (w) = Pr(H g = 0 | W g = w).

Pr(Wg>Zg∩Wg≥w) . Then

where

Therefore,

Remark S3.6. As shown in Keich et al. [13] , the usual target-decoy competition estimator for the global false discovery rate at some score threshold w is

, where the denominator is the total number of discoveries and the numerator is an estimate for the number of false discoveries. As decoy scores are meant to mirror those from all incorrect target matches, this estimator implicitly assumes (ii) in the statement of Lemma S3.1 holds. If q is large, Assumption (a) in the statements of Lemmas S3.1 and S3.2, along with other regularity conditions [38] , can be used to guarantee T DC(w) approximates PSM-FDR g Remark S3.7. Assumption (d) in the statement of Lemma S3.2 is a standard assumption, and is among the target-decoy assumptions listed in Keich et al. [13] .

As (i) and (ii) in the statement of Lemma S3.1 are responsible for the behavior of the PSM-fdr in existing methods, we discuss why they are invalid in nanobody data and the how they cause existing methods to underestimate score-ordering errors.

• Condition (i): X g is independent of Y g conditional on H g = 1. This is invalid in nanobody proteomes. If H g = 1 and due to the sequence similarity in nanobody peptide sequences, the generating peptide P g will almost surely resemble another peptide P g ∈ T . In this case, X g = Score(P g , S g ) ≈ Score(P g , S g ) ≤ Y g , implying Y g is dependent on X g .

. This is invalid in nanobody proteomes. To see this, suppose H g = 1. Since Z g is the top scoring decoy peptide, Z g will typically be much smaller than X g , since peptides in D bear no resemblance to nanobody peptides. However, as discussed above, X g will likely be similar to scores for other non-generating nanobody peptides, implying X g ≈ Y g . Therefore, Z g is stochastically smaller than Y g , which causes existing methods to underestimate the number of score-ordering errors (i.e. the number of times Y g > X g when H g = 1).

Assumption (ii) in Proposition 3.1 states that Bayes factor scores z (T ) g have the same distribution as z (D) g when spectrum g's generator lies outside the target database T . Since pvalues p g , defined in Proposition 3.1, are only valid if Assumption (ii) holds, this assumption is critical to controlling DI-fdr g , and consequently PSM-fdr g . We justify this assumption using the precursor mass shift technique outlined in Elias et al. [31] , whereby we randomly increased or decreased a spectrum's assigned precursor monoisotopic m/z by 10 m/z units. Given the high precursor mass accuracy of these data, and because it is assumed P ∈ T is a candidate generator only if its expected monoisotopic mass is within 10 parts per million of a spectrum's assigned monoisotopic mass, none of the spectra with an artificial m/z shift could have been generated by a peptide in T . Therefore, if Assumption (ii) were to hold, the distributions of the Bayes factor scores z (T ) g and z (D) g should be the same. Further, our estimates for π 0 in our simulation studies in Section 5, which gives the fraction of all spectra not generated by peptides in T , should be accurate. Figure S1 shows this both of these appear to be true.

Let pm (P ) , pm (Sg) be peptide P 's and S g 's predicted and observed precursor mass, respectively. Define X g = {m (P ) j : |pm (Sg) − pm (P ) | ≤ ∆, j ∈ [n (P ) ]} to be the set of signal m/z's that could appear in S g , which include peaks not included in S g 's generator's predicted Figure S1 : Simulation results from Section 5 suggesting the Assumptions in Proposition 3.1 are valid. (a): Density plots of Bayes factor scores from one simulation for spectra whose precursors were randomly shifted ±10m/z units, and therefore were generated outside the target database T . (b) Estimates for π 0 , defined as the fraction of spectra generated outside the database. Each point is a simulation, where "Med" is the median estimate across simulations.

spectrum, as well as peaks from co-fragmented peptides. The constant ∆ > 0 is determined by the mass spectrometer's precursor isolation window. For the remainder of Section S4, we make use of the following definition:

We begin with an assumption on X g .

Assumption S4.1. Let α ∈ (0, 1] and 0 < a < m * < b be constants, A : (0, ∞) → (0, ∞) a non-decreasing function, X 0 ⊂ [a, m * ) be a set with a finite number of elements, and X ⊂ [m * , b] a realization of a inhomogeneous Poisson process with intensity λ(x). Then for X g = {m ∈ X : m ≤ A{pm (Sg) }}, X g = X 0 ∪X g and λ is log α-Hölder continuous.

Remark S4.8. The set X 0 is meant to contain all unmodeled small m/z's, which represent peptide fragments with a small number of (1 or 2) amino acids. We differentiate these fromX g because, unlike the elements inX g , we are certain of their location. Due to the combinatorial explosion of moderate-to-large peptide fragments, we assumeX g is a realization of a Poisson process to capture our uncertainty about the location of unmodeled moderateto-large peptide fragments. Figures S2(b) and S2(c) show that the Poisson approximation appears to be a reasonable approximation for the distribution of peptide fragment m/z's.

Remark S4.9. The assumptions on X g ensure X g ⊆ X h if pm (Sg) ≤ pm (S h ) , and captures the fact that fragments of a small peptide P 1 will also be fragments of a larger peptide P 2 if P 1 is a sub-sequence of P 2 . It suffices to assume a = 57, since this is the mass of the smallest +1 b-ion.

Remark S4.10. We abuse notation by defining X 's intensity to be λ, which was Λ in the statement of Theorem 4.1 and is unrelated to λ (m) noi,g defined in the main text. Here, λ reflects the distribution of moderate-to-large peptide fragments (see Remark S4.8).

The assumption that λ is log α-Hölder continuous appears to be a reasonable assumption, where Figure S2 shows that unmodeled peptide fragments with moderate-to-large m/z's likely cluster in regions whose local distributions appear Gaussian with standard deviation substantially larger than the scale m/z × 10 −6 ω used to map observed m/z's to modeled m/z's described in Remark 4.2.

We next place assumptions on D and for D g = m∈X g p(m), letp g (x) = p(x)/D g be a probability mass function on X g . Then Γ g (m | y) is the density of the random variable M g = m g (10 −6 R g + 1), conditional on Y g = y and X g , such that R g | Y g = y has density d (m) sig (r | y) and m g | X g ∼ Categorical(X g ,p g ), where R g and m g are independent conditional on Y g , X g . Remark S4.11. As defined, B g (m) = α g B(m) is the density of spectrum g's contaminating background noise m/z's, which we assume is truncated at A{pm (Sg) }. It assumes that the relative frequency of contaminating peaks in different m/z regions is consistent across spectra. That is, if, for spectra g and h, pm

. This is consistent with existing noise models, which do not differentiate between contaminating peaks and unmodeled peptide fragments, and assume D (m) noi,g (m | y) ∝ 1 [14, 18] . Remark S4.12. Γ g (m | y) is the density of unmodeled peptide fragments in spectrum g. These include fragments from co-isolated peptides, as well as fragments from spectrum g's generating peptide that are not included in its predicted spectrum. Just as with B(m) in Remark S4.11 above, the assumption thatp g (m) ∝p h (m) for m ∈ X g ∩ X h implies the relative frequency of unmodeled peptide fragments in different m/z regions is consistent across spectra, which is consistent with our observations in real data (data not shown). The probability mass functionp g can also be interpreted as a completely random probability measure [39] , which is ubiquitous class of random measures generated by normalizing non-negative functions of inhomogeneous Poisson process.

Remark S4.13. The assumption that p is continuous is akin to assuming it is locally constant, and implies we are more likely to observe m/z's from regions with dense clusters of potential signal m/z's. Using as an example the data in Figure S2 (a), this suggests we are more likely to observe noise m/z's around 931.4 than we are around 931.2. Further, the continuity of B, p, and λ helps ensure D (m) noi,g (m | y) is continuous in m, and is justified by the observation that continuous, non-uniform noise densities have previously been used to simulate realistic high mass accuracy MS/MS spectra [40] . 

In the remainder of this section, state four theorems that use Assumptions S4.1 and S4.2 to justify the following: sig (r | y) and a uniform distribution for small m, and Theorem S4.3 uses the fact that #m/z's in F m = m ∈X g I(m ∈ F m ) is typically large for large m (Figure S2(b) ) to prove d (m) noi,g (r | y; m) can be approximated with a uniform distribution for large m.

Studying the behavior of d noi,g (r | y; m) = 10 −6 m Pr{M g = m(10 −6 r + 1) | Y g = y, M g ∈ F m , m ∈ X g , X g }.

First, Theorem S4.2 considers 10 −6 m Pr{M g = m(10 −6 r + 1) | Y g = y, M g ∈ F m , m ∈ X g }, which captures the average behavior of d (m) noi,g (r | y; m) over possible instantiations of X g , and shows this is a mixture of d (m) sig and a uniform distribution. We condition on m ∈ X g , where m = m (P ) j for some peptide P and predicted ion j, because when we score P we observe m. We then show in Corollary S4.1 that the model for d 

where log{π g (m)} is α-Hölder continuous as a function of m.

Remark S4.14. Figure 3 (h) suggestsπ g (m) is small for small m, which suggests that π 0 is also small.

According to Figure S2(b) , the m ∈ X 0 for m corresponding to one or two amino acidlong fragment ions. We next study how Pr(u | u ∈ F m , v, m ∈ X g ) for moderate to large values of m. 

where log{π g (m)} is α-Hölder continuous as a function of m.

Remark S4. 15 . Theorem S4.2 shows that Model (4.8) captures the average behavior of d (m)

noi,g (r | y; m) over possible instantiations of X g , which reflects our uncertainty regarding the exact positions of unmodeled signal m/z's.

2 is an estimate for λ(m),Ñ (m) is an extrapolation estimate for the number of m/z's in F m . The expression forπ g in Theorem S4.2 matches that in Theorem S4.1 whenÑ m = 0, and as shown in Corollary S4.2 below,π g (m) approaches 1 when the number of unmodeled signal peaks in F m increases. Since π 0 is likely close to 0 (see Remark S4.14) and the normalizing term p(m) + m ∈X g \{m} p(m ), under trivial assumptions (see Corollary S4.1), will concentrate around its expectation,π g (m) ≈ E{Ñ mpg (m)}/ E{(Ñ m + 1)p g (m)} ≈ E(Ñ m )/ E(Ñ m + 1) has little dependence on g.

We next state two corollaries of Theorem S4.2.

Corollary S4.1. In addition to the assumptions of Theorem S4.2, suppose the following hold for D g = m ∈X g p(m ) and E g = E(D g ):

(ii) m 1 < · · · < m K ∈ X g ∩(m * /(1 − η) , ∞] such that G m 1 , . . . , G m K are non-overlapping, p(m k ) ≥ c 2 for all k ∈ [K], and K ≤ c 3 E δ g for constants c 2 , c 3 > 0 and δ ∈ (0, γ/2).

Define R(u, m) = 10 6 (u − m)/m to be the relative mass error. Then for all r ∈ [−ω, ω] and E g large enough,

where |log(π g ) − log{π g (K −1 K k=1 m k )}| = O(|m 1 − m K | α ). Remark S4.17. Corollary S4.1 provides a second interpretation of Theorem S4.2, and shows that (4.8) reflects the average behavior of d (m) noi,g (r | y; m k ) across neighboring intervals F m k . Remark S4.18. The random variable D g is used to definep g (m) = p(m)/D g , where the assumption that CV g = O[{E(D g )} −γ ] in (i) of Corollary S4.1 simply assumes that the functionp g concentrates around the non-random function p(m)/ E(D g ). This assumption is quite general, and holds whenever p(m), m ∈ R ⊂ R, is bounded from below for a sufficiently large set R. For example, if R is the range of X g , then γ = 1/2. We derive expressions for E(D g ) and Var(D g ), as well as concentration results for D g , in Lemma S8.4 in Section S8.2. Assumption (ii) is technical and simply assumes that K (the number of m/z's m k ∈ X g we are considering) is small with respect to E(D g ), which is very large.

Then under the assumptions of Theorem S4.2,π g (m) = 1 − O(N −1 m ). Remark S4. 19 . Corollary S4.2 shows that 10 −6 m Pr{M g = m(10 −6 r + 1) | Y g = y, M g ∈ F m , m ∈ X g } is approximately uniform for large N m , which as suggested in Figure S2(b) , holds for nearly all moderate to large m/z's m. noi,g (r | y) is approximately uniform when N m is large. As shown in Figure S2 noi,g only depends on g throughπ g (andπ g in Corollary S4.1). It is easy to see that if π 0 is small and D g , defined in Corollary S4.1, concentrates around its expectation, thenπ g has little dependence on g. Remark S4.14 argues that the former is true, and we justify the latter in Remark S4.18. 

, ∞) and on the event G m ∩ X g = {m}. 

whereÑ m andp g (m) are as defined in (S4.2).

Remark S4.22. The expressions in (i)-(iv) in Theorem S4.4, as well as (S4.4) in Corollary S4.3, have no dependence on y. Further, they will be similar across spectra g if π 0 is small and the majority of the mass ofp g (m)N m concentrates around relatively small m/z's m.

The former, as indicated in Remark S4.16, appears to be true. The latter follows from the fact that ifp g (m)N m is largest for small m, the normalizing constant m∈X g p(m) will be similar for all g, implyingp g (m) ≈p h (m) provided m ∈ X g ∩ X h . The large probability mass for small m/z in Figures 3(i) and S3 suggest this is the case for spectra with +2 precursor charge, and is approximately true for +3 and ≥ +4 precursors. 

S5.1 Calculating BF g (P ) given hyperparameters noi,g (m) obtained from group 1 datasets for different charge state and precursor mass bins. These are the bins used to analyze our real data, where the precursor mass bin partitions are the median precursor mass for training spectra with that precursor charge. 

which we approximate using a Laplace approximation. Next,

where X (a; b) is the density at a of a χ 2 b . We first note that for fixed µ g , h noi (µ g ) is trivial and h sig (µ g ) can easily be approximated with a Laplace approximation. However, since log{h noi (µ g )} is a seventh degree polynomial and h sig (µ g ) does not have an analytic form, it is difficult to quickly calculate or approximate x (int) with standard methods. To circumvent this, we note that due to the large number of noise peaks in MS/MS spectra and because µ g is the mean log-intensity of noise peaks,ȳ

noi is normally distributed, we therefore approximate x (int) as h sig (μ g )h noi (μ g ). Lastly, we use a similar technique to approximate z (int) as

Here we describe our estimates for the signal hyperparameters

sig , σ 2 m,1 , σ 2 m,2 } ⊂ Θ (ma) . We first note that the estimates for Θ (rt) and {f (m) sig , σ 2 m,1 , σ 2 m,2 } ⊂ Θ (ma) were the same for all precursor charges, whereas the remaining estimates depend on precursor charge, where we partition precursor charge as +2, +3, and ≥ +4. We apply the same partition in Section S5.3. For both this set of hyperparameters and the noise hyperparameters estimated in Section S5.3, we first curate a set of high-confidence peptide-spectrum matches (PSMs) using an existing search engine. For the estimates shown in Figure 3 and used in Sections 5 and 6, we used the commercial software Proteome Discoverer [32] licensed by Thermo Fisher Scientific to identify PSMs at a 1% decoy-determined false discovery rate (FDR) with normalized delta scores > 0.05. The second criterion ensures the selected PSMs have unambiguous score ordering, which, as shown in Figure 1 , is important in nanobody proteomes. As indicated in Figure S4 , we find that the search engine has little to no effect on hyperparameter estimates.

For the Θ (rt) , we fit the quadratic function f (t) sig by regressing logit{t g /M } onto spectrum g's generator's indexed retention time, iRT P , using Huber's loss to account for any potential incorrectly assigned PSMs. We then estimate σ 2 t,1 , σ 2 t,2 , and π t using an EM algorithm. To estimate the remaining hyperparameters, we map predicted peaks j to observed peaks i for each PSM using the procedure outlined in Remark 4.2. We then estimate µ gen and Σ gen as

where q is the number of spectra in the training set. We note that the map δ and matched peptide P implicitly depend on the spectrum g.

For µ β , σ 2 β , φ, and v, we use ordinary least squares (OLS) to regress {y

, which gives us an estimate for β g ,β g , an estimate for Var(β g | β g ), s 2 g , and an estimate for σ 2 y,g ,σ 2 y,g , where we note that I sig implicitly depends on g. We then letμ β = q −1 q g=1β g and estimated σ 2 β as the method of moments estimatorσ 2

Finally, we estimate φ and v using maximum likelihood assuminĝ

where we note that both I sig and I noi implicitly depend on g. We then letΣ int be the method of moments estimator

whereâ 2 g is the sample variance of {y (Sg) i } i∈I noi andb 2 g is the estimate for the variance of the OLS estimate for the intercept in the regression described in the previous paragraph.

Lastly, for f (m) sig , σ 2 m,1 , and σ 2 m,2 , let r δ(j) , j ∈ δ −1 (|I sig |), be as defined in step (iv) of Algorithm 4.1, where we assume {r δ(j) } j∈[n (P ) ];g∈[q] are independent and identically distributed. Note that δ implicitly depends on spectrum g. Assuming f (m) sig is a constant, we first use an EM algorithm to estimate σ 2 m,1 , and σ 2 m,2 . We next estimate f (m) sig using a second EM algorithm by fixing the estimates for σ 2 m,1 , and σ 2 m,2 . The estimates changed only slightly upon iterating this procedure.

Remark S5.24. The estimates for the priors of (α g , δ g ), (µ g , γ g ), β g , and σ 2 y,g in Figure S4 demonstrate the inter-spectra heterogeneity. For example, the coefficient of variations for α g and σ 2 y,g , defined in (4.4) and (4.5), ranges from 0.34 to 0.36 and 0.15 to 0.23, respectively.

It remains to define estimates for the noise hyperparameters D noi (r | m; y), where the first two were found to depend on precursor charge, and the third showed little dependence on precursor charge. We therefore return three estimates for the first two (one for each precursor charge group defined in Section S5.2 above) and one Prior for α g & Δ g (mean(α g ), mean(Δ g )) (sd(α g ), sd(Δ g ), corr(α g , Δ g )) Prior for µ g & γ g (mean(µ g ), mean(γ g )) (sd(µ g ), sd(γ g ), corr(µ g ,γ g )) Figure S4 : A comparison of the signal hyperparameter estimates derived from Proteome Discoverer and Crux, a commonly used open-source method to score peptide-spectrum matches [11] . We used Proteome Discoverer to derive hyperparameters in Figure 3 , Section 5, and Section 6. noi } i∈I noi ,g∈ [q] , where q is the number of training spectra in the precursor charge bin, I noi implicitly depends on g, and y (Sg)

. We then use the technique outlined in Efron et al. [41] to regress bin counts N s onto their midpoints m s assuming N s | m s ∼ Poi{N ∆ m exp( 7 k=0 b k m k s )}, where N is the total number of points, ∆ m is the bin width, and b k are the regression coefficients. The density estimate isD (y) noi (y) ∝ exp( 7 k=1b k y k ), and we normalizeD (y) noi (y) so that it integrates to 1. The choice to make the log density a seventh degree polynomial was to ensure estimates were unbiased and consistent across different training sets, although estimates were similar when we let the degree be as low as five. Histogram bin width ∆ m had a negligible effect on estimates.

We next present our estimator for d sig , threshold ∆ > 0, a target (i) Given ∆, let N g be as defined step (i) of Algorithm S5.1, and letÑ g = {m ∈ N g : m is not the m/z of a b1, b1 c , y1, or y1 c ion in P g 's predicted spectrum}, where the superscript "c" denotes the ion's complement.

(ii) For M g as defined in step (ii) of Algorithm S5.1, letM g = {m > 0 : m ∈Ñ g and (m, r(m,m),ŷ) ∈ M g }.

(iii) Repeat steps (i) and (ii) for all training spectra in group j. For n (Sg) noi the number of peaks in S g after removing its matched signal peaks, definê

,

where |E| is the number of elements in the set E.

(iv) Let m s be the midpoint of bin B s . Then log{ĝ j (m)} is the estimator obtained by regressing log(b js ) onto m s for m s > t using B-splines of degree three.

Remark S5.25. Like step (i) of Algorithm S5.1, N g in step (i) of Algorithm S5.2 is meant to contain elements from X g defined in both Theorem 4.1 and Assumption S4.1. We define N g in terms of the fragments of a potentially observable peptide to sample the space of peptide fragment m/z's that may generate a noise peak in S g , which circumvents having to enumerate X g . We further restrict N g to be the elements inÑ g in Algorithm S5.2 because noise peaks cannot exist in the regions surrounding P g 's predicted m/z's after S g 's matched signal m/z's have been removed. We only remove P g 's b1, y1, and their compliment ions to simplify the implementation of Algorithm S5.2, but note that including additional ions in this exclusion set had a negligible effect on the estimatorλ Remark S5.27. If m ∈ B s is the predicted m/z of a peptide fragment, the estimatorp gjs in step (iv) of Algorithm S5.2 is the method of moments estimator for the probability a noise peak in spectrum g is within ω parts per million (ppm) of m. Our data processing procedure outlined in Section 2 ensures only one noise peak can lie within ω ppm of any peptide fragment m/z in practice.

We assume that noise log-intensities are drawn from a location family of distributions. That is, y (Sg) i ∼ µ g + Y gi for i ∈ I noi , where µ g is defined in step (ii) of Algorithm 4.1 and Y gi is a mean zero random variable with density D (y) noi (·). This differs from previous work that assumes {y (Sg) i } i∈I noi ,g∈ [q] are independent and identically distributed [10, 14, 18] , or simply normally distributed [26] . Figure S4 (c) suggests the variation in µ g is non-trivial (CV(µ g ), its estimated coefficient of variation, is around 0.2), indicating E{y (Sg) i } is spectrum-specific. To explore how other aspects of y (Sg) i 's distribution vary across spectra g, we examined the variation in y (Sg) i 's scale, skew, and tails across spectra using Tukey's g-and-h family of distributions [42] . Briefly, we used quantile least squares to fit the following model for each training spectrum g in the dataset:

where we abuse notation and let the subscript "g" index spectrum and "g" be a parameter.

Here, a g = median{y (Sg) i }, b g gives the scale, g g specifies the skew, and h g ≥ 0 determines the size of y (Sg) i 's tails. Since nearly all estimates for h g were exactly 0, we set h g = 0 for all spectra g. We then used the asymptotic results derived in Xu et al. [43] in conjunction with ashr [44] to derive empirical Bayes prior distributions b g ∼ Π b (·) and g g ∼ Π g (·). We used these priors to estimate that CV(b g ), CV(g g ) < 0.1, which suggests that in comparison to the variation in noise location, the variation in scale, skew, and tail size is trivial, and was therefore assumed to be zero.

The uniform noise model was chosen to match that used in Li et al. [14] and Wan et al. [18] , and was defined to be D } i∈[n (Sg ) ] for observed spectrum S g . As a consequence, the probability a noise peak i ∈ I noi gets mapped to predicted peak j is min is typically comparable with S g 's precursor's mass. Since ω = 20 in our application, this probability is O(10 −5 ).

We compared MSeQUiP's model for noise m/z's to the uniform model in Section 5 by replacing λ 

Here we include additional simulation results comparing inference with MSeQUiP and existing scoring functions that incorporate relative intensity information. The latter include the SimScore [45] , ion fraction [16] , and spectral angle (SA) [16] , and, for I p and I o the predicted and observed relative intensities, are defined as

where f is a strictly decreasing function. We note that SA is used by Gessulat et al. [16] as the loss function to train their spectrum prediction machine learner, and both SA and IonFrac are used by Prosit [16] to rank peptides. We used each scoring function to score potential generators, and defined each method's inferred generator to be the peptide that gave the maximum (SimScore, IonFrac) or minimum (SA) score. The results are given in Figure S5 .

We first provide PSM-fdr calibration results for all group 2 PSMs, where group 2 contains the three datasets analyzed in Section 6, in Figure S6 . While MSeQUiP performs markedly better than all competing methods, we hypothesize its slight inflation is due to the incompleteness of T a and cross-antigen degeneracies in nanobody framework, CDR1, and CDR2 regions [34] , which, as discussed in Section 6.4, could imply T b contains non-CDR3 generating peptides.

To further demonstrate the calibration of MSeQUiP's PSM-fdr, we evaluated MSeQUiP's performance on the three group 1 datasets by repeating the analysis used to generate Figure 7(a) . Figure S7 contains the results. Note that group 1 data were used to train Algorithm 4.1's hyperparameters in both the group 1 and group 2 analyses. Nominal PSM-fdr Fraction of CDR3 PSMs from Lama 2 in PSM-fdr bin Figure S7 : PSM-fdr calibration results for the group 1 and group 2 datasets. The black curve is the exact same as that plotted in Figure 7 (a). g | J g } for simulated spectra g with PSM-fdr g ≤ 0.2, where each point represents a simulation andPr{D

Here we argue that the entrapment false discovery proportion (FDP) used in Section 6.4 of the main text to evaluate the fidelity of MSeQUiP's and existing methods' PSM-fdr's is justified. The entrapment FDP is the fraction of the number of CDR3 PSMs that match to T b , where |T b |/|T a ∪ T b | = 0.48 and 41% of CDR3 PSMs matched to a peptide from T b . Since some CDR3 PSMs from T a may also be incorrect, the entrapment FDP is a lower bound on the fraction of incorrect PSMs.

To elaborate on this, let J g = {PSM g is incorrect} and D (j)

To show this is the case for MSeQUiP, we note that because of the sharp contrast from other work arguing existing methods control database incompleteness errors and perform well in standard proteomes whose PSMs are not prone to score-ordering errors [35] , as well as their small delta scores for known incorrect CDR3 PSMs (Figure 7(c) ), we hypothesize that the majority of incorrect CDR3 PSMs are the result of score-ordering error, as opposed to database incompleteness errors. This is supported by the fact that even though existing methods inflate PSM-fdr's (see Figure 7) , there was substantial overlap between the spectra MSeQUiP and existing methods identify as significant ( Figure S8(a) ). For example, since MS-GFplus returns egregiously inflated PSM-fdr's, only 68% of its significant PSMs overlap with MSeQUiP's. However, over 80% of their significant spectra overlapped, suggesting that the ambiguity was not so much whether the spectrum was generated by a peptide in the target database, but rather the spectrum's correct match. Therefore, we argue Pr{D

for H g as defined in Section 3.

We used simulated data to show this. Briefly, we re-analyzed the simulated data from Section 5 by matching spectra to all peptides from T a ∪ T b , where since simulated spectra where all generated by peptides in T a , matches to T b are known to be incorrect. For each of the 50 datasets we simulated, we definedPr{D (b) g | J g } to be the fraction of incorrect PSMs that matched to D (b) g , where Figure S8 (b) contains results for PSMs with PSM-fdr g ≤ 0.2. We chose this PSM-fdr threshold because all but 5% of MSeQUiP-derived PSMs in Figures 7(a) and S7, and all but 20% in Figure 7 (b), have score-ordering error rate bounded above by 0.2. These results suggest Pr{D (b) g | J g , H g = 1}, and therefore Pr{D (b) g | J g }, is approximately 1, which indicate the y-axes in Figures 7(a), 7(b) , and S7 mirror MSeQUiP's true false discovery proportion.

We hypothesize this result suggesting incorrect, but nominally correct, matches are more likely to match T b than T a is due to us only considering PSMs with small PSM-fdr's. To see this, suppose a spectrum was generated by a peptide P ∈ T a but the match P , which may be in T a or T b , is different from P . If P ∈ T a , then since CDR3 peptides in T a bind to Antigen a and therefore have similar sequences, P will likely be similar to P . As such, even though BF g (P ) may be large, BF g (P ) ≈ BF g (P ), implying the PSM-fdr will be large, and therefore is unlikely to be considered by MSeQUiP. However, if P ∈ T b , then because of the dissimilarity between Antigen b and Antigen a , P will not necessarily be similar to P ∈ T a . Therefore, given that we are only considering relatively small PSM-fdr's, these should be dominated by PSMs that match to T b . To provide additional support for our hypothesis, we also considered PSMs with PSM-fdr's between 0.4 and 0.6, as these imply BF g (P ) ≈ BF g (P ), and consequently suggests P is similar to P . If our reasoning is valid, incorrect PSMs from this set should therefore be dominated by T a matches. We observed this to be the case, as nearly 80% of these incorrect PSMs had peptide matches from T a .

S8.1 Proof of Proposition 3.1

We first prove Proposition 3.1 from the main text.

Proof of Proposition 3.1. We can re-write p g as

h }]/(q + 1),

where I{z S8.2 Proofs of theoretical statements made in Section S4 Lemma S8.3. Suppose log{f (x)}, log{g(x)} are α-Hölder continuous on the compact interval I. Then log{f (x) + g(x)} is α-Hölder continuous on I.

Proof of Theorem S4.2. Let G m = [m 1−10 −6 ω 1+10 −6 ω , m 1+10 −6 ω 1−10 −6 ω ] and define the random sets R 1 = G m ∩(X g \{m}) and R 2 = G c m ∩(X g \{m}). Note thatd (m) sig (u | y; m ) = 0 if u ∈ F m and m ∈ G c m . Conditional on m ∈ X g , the random normalizing constant is β −1 g = m ∈R 1 p(m ) + m ∈R 2 p(m ) + p(m) = P 1 + P 2 + p(m), where P 1 and P 2 are independent with distributions that implicitly depend on g. Then Pr(M g = u | Y g = y, m ∈ X g ) = π 0 α g B(m) ( .

Let N 1 be the number of elements in R 1 , and for ease of notation, set δ m = L(F m ). Then where |c(R 1 , R 2 , R 3 , R 4 , m 1 , m 2 )| ≤ M for some constant M that does no depend on R 1 , R 2 , R 3 , R 4 , m 1 , m 2 or g. Therefore,

E{Ñ m 2p g (m 2 )} E{Ñ m 2p g (m 1 )} − 1 ≤ k 1 |m 1 − m 2 | α for some universal constant k > 0. It is easy to see that these same techniques can be used to show that log[E{p g (m)}] is α-Hölder continuous. Therefore, we need only show that E{Ñ m 2p g (m 1 )} E{Ñ m 1p g (m 1 )} − 1 ≤ k 2 |m 1 − m 2 | α for some constant k 2 > 0. To do this, we see that Pr{R(M gk , m k ) = r | X g } = a k + M k P k + D/p(m k )

, a k = π 0 α g B(u k )(10 −6 m k )

Pr(M gk ∈ F k | X g ) = b k +M k P k + D/p(m k ) , b k = π 0 α g ∫ where the terms in the summand in the expressions for M k andM k are uniformly bounded from above. We can therefore write the denominator of (S8.5) as

where (M 1 ,M 1 ), . . . , (M K ,M K ) are independent and a 1 , b 1 , P 1 , . . . , a K , b K , P K are deterministic. When factored, the expression inside the expectation will be the sum of 2 K terms. We first study last term, which can be expressed as E K j=1M j P j + D/p(m j ) = E K j=1 P j + E/p(m j ) P j + D/p(m j ) K j=1M j P j + E/p(m j ) ,

where our analysis can then be easily extended to the remaining 2 K − 1 terms. This term can be re-written as Lemma S8.6. Suppose the assumptions of Corollary S4.1 hold and let E = E{ m∈X g p(m)I(m / ∈ {m 1 , . . . , m K })}. Then

where the error is uniform across r ∈ [−ω, ω].

Proof. Let S(r | X g ) = K −1 K k=1 f k (r | X g ). Then

where the second equality follows because f k (r | X g ) is uniformly bounded from above. Next, for k 1 = k 2 ∈ [K], Cov{f k 1 (r | X g ), f k 2 (r | X g ) | F} = E[Pr{R(M gk 1 , m k 1 ) = r | X g } Pr{R(M gk 2 , m k 2 ) = r | X g } j / ∈{k 1 ,k 2 } Pr(M gj ∈ F m j | X g )]

E{Pr(M gk 1 ∈ F m k 1 | X g ) Pr(M gk 2 ∈ F m k 2 | X g ) j / ∈{k 1 ,k 2 } Pr(M gj ∈ F m j | X g )} − E{f k 1 (r | X g ) | F} E{f k 2 (r | X g ) | F}.

Identical techniques used in the proof of Lemma S8.5 can be used to show that this is O(E −α+2δ ), where the error is uniform across k 1 , k 2 and r. This completes the proof.

Lemmas S8.5 and S8.6 shows that

for E defined in the statements of Lemmas S8.5 and S8.6. The results then follow by Theorem S4.2. for some universal constant c 5 > 0. Lastly, let B(a, ∆) ⊆ F m be a closed ball centered at a with radius ∆ > 0, and for u 1 , u 2 ∈ B(a, ∆), define I = X g ∩(G u 1 ∩ G u 2 ) and R = X g ∩{(G u 1 ∪ G u 2 ) \ (G u 1 ∩ G u 2 )}. Then Proof of Corollary S4.3. The proof of Corollary S4.3 is a simple extension of the proof of Corollary S4.1, and has been omitted.

Naturally occurring antibodies devoid of light chains

The Therapeutic Potential of Nanobodies

Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2

Integrative proteomics identifies thousands of distinct, multi-epitope, and high-affinity nanobodies

A robust pipeline for rapid production of versatile nanobody repertoires

Computational Mass Spectrometry-Based Proteomics

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

A method for reducing the time required to match protein sequences with tandem mass spectra

Andromeda: A Peptide Search Engine Integrated into the MaxQuant Environment

MS-GF+ makes progress towards a universal database search tool for proteomics

Computing Exact p-values for a Cross-correlation Shotgun Proteomics Score Function

Fast and Accurate Protein False Discovery Rates on Large-Scale Proteomics Data Sets with Percolator 3.0

Controlling the FDR in Imperfect Matches to an Incomplete Database

A likelihood-based scoring method for peptide identification using mass spectrometry

Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis

Prosit: proteome-wide prediction of peptide tandem mass spectra by deep learning

High-quality MS/MS spectrum prediction for data-dependent and data-independent acquisition data analysis

PepHMM: A Hidden Markov Model Based Scoring Function for Mass Spectrometry Database Search

YADA: a tool for taking the most out of high-resolution spectra

Approximating Isotope Distributions of Biomolecule Fragments

A direct approach to false discovery rates

Non-parametric estimation of posterior error probabilities associated with peptides identified by tandem mass spectrometry

Improved False Discovery Rate Estimation Procedure for Shotgun Proteomics

The MaxQuant computational platform for mass spectrometry-based shotgun proteomics

Best Practice Guide: Methodology for Accurate Mass Measurement of Small Molecules

A statistical approach to peptide identification from clustered tandem mass spectrometry data

Learning Peptide-Spectrum Alignment Models for Tandem Mass Spectrometry

Modeling peptide fragmentation with dynamic Bayesian networks for peptide identification

Filtering of MS/MS data for peptide identification

Comparison of Probability and Likelihood Models for Peptide Identification from Tandem Mass Spectrometry Data

Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry

Proteome Discoverer-A Community Enhanced Data Processing Suite for Protein Informatics

Rapid Distinction of Leucine and Isoleucine in Monoclonal Antibodies Using Nanoflow LCMS n

Diversity in the CDR3 region of V(H) is sufficient for most antibody specificities

Using the entrapment sequence method as a standard to evaluate key steps of proteomics data analysis process

qvalue: Q-value estimation for false discovery rate control. R package version 2

Faster SEQUEST Searching for Peptide Identification from Tandem Mass Spectra

Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach

Completely random measures

MaSS-Simulator: A Highly Configurable Simulator for Generating MS/MS Datasets for Benchmarking of Proteomics Algorithms

Using specially designed exponential families for density estimation

The Tukey g-and-h distribution

Robust Estimation of the Parameters of g-andh Distributions, with Applications to Outlier Detection

ashr: Methods for Adaptive Shrinkage, using Empirical Bayes. R package version 2.2-50

Improved Validation of Peptide MS/MS Assignments Using Spectral Intensity Prediction

database T , and training spectra S g whose matched signal peaks have been removed. Output: Estimates for a 0 , a 1 ∈ R used to define the function f (m) noi (m) = a 0 + a 1 log(m).(i) Fix g and let N g be sampled uniformly at random from S g = {{b/y ion m/z's with charges 1 through min(3, z g ) from a randomly permuted peptide in T with monoisotopic mass pm} : |pm g − pm| ≤ z g ∆}.(ii) Use the procedure outlined in Remark 4.2 to map predicted m/z's m ∈ N g to noise m/z'sm in S g , where m matchesm if r(m, m) = 10 6 |m/m − 1| ≤ ω. Let M g = {(m, r(m, m),ŷ)} m andm match , whereŷ is the log-intensity of the noise peak with m/ẑ m.(iii) Repeat steps (i) and (ii) for all spectra g ∈ [q], where q is the number of training spectra.sig {r(m, m) |ŷ} for U ±ω (r) the density at r of a U [−ω, ω] and π noi (m) = expit{a 0 + a 1 log(m)}, estimate a 0 and a 1 via maximum likelihood using {M g } g∈ [q] and an EM algorithm.To make Algorithm S5.1 as principled as possible, we let ∆ be the mass spectrometer's precursor isolation window. However, we note that varying ∆ or defining S g from step (i) in terms of the precursor's relative part per million mass accuracy 10 6 |pm g /pm − 1| ≤ ∆ resulted in virtually identical estimates for a 0 and a 1 . We discuss our choice for N g in Remark S5.25 after the presentation of Algorithm S5.2 below.We lastly describe our estimate for λ (m)noi,g (m). For each precursor charge group defined in Section S5.2, we partition spectra by precursor monoisotopic mass pm g using the below partition, where λ where m 3 and m 4 are the median pm g for training spectra with z g = +3 and z g ≥ +4, respectively. This partition, consisting of five groups, was chosen because λ (m) noi,g (m) appeared consistent within each group. For the purposes of Algorithm S5.2 below, we let J : N × R → [5] define the above partition (i.e. J (z g , pm g ) = j if g's precursor charge-mass pair falls in group j ∈ [5] ) and λ, and training peptidespectrum match pairs (P g , S g ) such that J (z g , pm g ) = j. Output: The estimatorλwhere the latter holds by the assumptions on f (x), g(x). for some universal constant t > 0 that does not depend on p or λ.Proof. The expressions in (i) are straightforward. For (ii), we see thatLet C = V 1/2 /M . Since p(x) ≥ 0 has maximum 1, there exists a t * > 0 that does not depend on p or λ such that K(t) ≤ t 2 V for all t ∈ [0, t * ], meaningThis completes the proof.For the remainder of the section, we definẽ , j = 1, 2, 3. This shows that log[E{Ñ mpg (m)}] is α-Hölder continuous, and completes the proof.Proof of Corollary S4.1. We implicitly condition on the eventin all probability statements in the proof. Let F = {M g1 ∈ F m 1 , . . . , M gK ∈ F m K } for M gk the kth (random) observed noise m/z, where M gk is identically distributed to M g . DefineWe break this proof into two smaller lemmas. First, we show that E{f k (r | X g ) | F} ≈ f k (r). Second, we prove that Var{ K k=1 f k (r | X g )} is small. Lemma S8.5. Suppose the assumptions of Corollary S4.1 hold and let E = E{ m∈X g p(m)I(m / ∈ {m 1 , . . . , m K })}. Thenwhere the error is uniform across r ∈ [−ω, ω].Proof. Note that M g1 , . . . , M gK | X g are independent. Define the function R(m 1 , m 2 ) = 10 6 (m 2 /m 1 − 1). Then(S8. 5) for u m ∈ F m defined in the proof of Theorem S4.1. Assumption S4.2(a) impliesTherefore, wee need only understand how {k(y, m)} −1sig (u | y; m ) behaves. Define δ = 10 −6 ω. We see that forLet A ⊆ F m be Lebesgue-measurable and define G A = ∪ x∈A (x/(1 + δ), x/(1 − δ)). ThenLet φ µ,σ (x) be the pdf of a normal with mean µ and variance σ 2 . Then for σ j,x = 10 −6 σ m,j x for σ m,j , j = 1, 2, defined in (4.6),π sig,j (y)k j ∫ x∈Gu φ u,σ j,x (x)dx π sig,1 (y) = π sig (y), π sig,2 (y) = 1 − π sig (y), k −1 j = ω/σ m,j ∫ −ω/σ m,j φ 0,1 (z)dz.We first see thatTherefore,for some constant c 1 that does not depend on x or u. We then see that p(x)λ(x).